Expression of eukaryotic genes follows a highly ordered sequence of events from initiation of transcription to translation of a mature mRNA within various subcellular compartments. All along this process a large number of different RNA binding proteins dynamically interact with target RNA to affect all aspects of the biogenesis of a mRNA and its translation by associating into large particles (for reviews, see references 14, 18, 30, 39, and 61) . Elucidation of mechanisms that allow RNA binding proteins to specifically recognize the complements of their target RNAs in a complex cellular environment is central to understand the role that RNA binding proteins play in posttranscriptional gene regulation.
RNA binding proteins have a modular composition consisting of one or more RNA binding domains and, in most cases, at least one additional auxiliary domain (18, 30, 39, 61) . The RNA recognition motif (RRM) is the most prevalent RNA binding domain and also one of the most frequent protein domains in eukaryotes (3, 10, 17, 18) . The ϳ80-amino-acid RRM contains two highly conserved short motifs, RNP1 and RNP2, and folds into a characteristic structure of a fourstranded antiparallel ␤-sheet and two ␣-helices that binds 4 to 7 nucleotides (nt) (59) . Binding specificities for many RRMcontaining proteins have been studied in detail with short sequences in vitro (18, 52, 61) . Predicting sequence-specific binding in a larger context, however, is difficult due to sequence redundancy and therefore relies mainly on experimental determination of binding sites (see, e.g., references 9, 20, 35, 57, and 58).
The ELAV/Hu family of RNA binding proteins is characterized by three RRMs and by their predominant expression in neurons (4, 42) . ELAV (embryonic lethal abnormal visual system), originally identified in Drosophila (48) , has been shown to affect neuronal pre-mRNA processing as a gene-specific regulator (29) . In contrast, the neuron-specific members of the human ELAV family, HuB (Hel-N1), HuC, and HuD, similar to the ubiquitously expressed HuA (HuR), have been attributed only cytoplasmic RNA-processing functions (6, 9, 19, 31, 33) . Common to ELAV/Hu proteins is their preferential binding to AU-rich sequences that are also frequently clustered, as, e.g., found in the c-myc 3Ј untranslated region (UTR) (1, 20, 32, 50) . Since AU-rich sequences are abundant in intronic and untranslated regions, it has not been clear how ELAV/Hu proteins achieve gene-specific binding resulting in distinct phenotypes in neuronal development and plasticity (6, 36, 43, 45) .
ELAV is essential for producing neuroglian (nrg) and erect wing (ewg) neuronal mRNAs, which require splicing of the terminal intron, resulting in distinct 3Ј ends (27, 34, 55) . In ewg splicing regulation, ELAV's effect is attributed entirely to the inhibition of 3Ј-end processing, as no reduction in splicing efficiency is seen when the ELAV binding site is mutated in the absence of a functional poly(A) site at pA2 (55) . ELAV binds to a stretch of AU-rich sequence (divided into elements m1, m2, and m3) (Fig. 1E ) extending over 135 nucleotides 3Ј of the regulated poly(A) site (pA2) and inhibits intronic 3Ј-end processing to allow neural splicing ( Fig. 1D) (55) .
Here we analyze the properties of an ELAV complex and its binding site on ewg RNA in relation to ELAV-controlled splicing regulation of the last ewg intron in neurons. We demonstrate that ELAV assembles on ewg RNA pA2-I to a dodecameric complex. Further, a combination of in vitro and in vivo analyses along with phylogenetic comparisons allows us to con-clude that the ewg ELAV complex binding site consists of a number of spaced AU 4-6 motifs spread over 135 nt. Furthermore, in vitro binding data support that functionally conserved AU 4 motifs in the 3Ј region of the 135-nt ewg binding site act as initiation sites for ELAV binding and complex formation.
MATERIALS AND METHODS
Fly genetics and recombinant DNA technology. Fly breeding, genetics and transformation, and recombinant DNA technology were according to standard procedures as detailed by Soller and White (55) . Additional mutations in the ELAV binding site of ewg were generated by site directed mutagenesis using the following oligonucleotides (antisense): spacer A, CAAAAAATGTATATTCCTGGTTGTTA T TAAT TTTTATTTTTAATTATGAGACCAACAATAATTAAAAATAAA AATTAATTTGAAG; spacer B, CAAAATATACTTACATATTATATTTT ACTCCTGTTCGTTTTTTACATAACTCAATATAAAATGAGGACAAG; and spacer C, CTGGTTAAAAGAAAAGAACATAAAGTATAAAATTATATTCTA TTTTACATATTATCGTTTTATATGAAGATAAAATGTATAATAG. pA2-I contains the sequence after the AAUAAA up to 6 nucleotides of exon I in a modified pB SKϩ, adding the vector sequence GGGCGAATTGGGTACGATCC TCTA-ewg pA2-I-GGCCGCCACCGCGGTGGAG to the ewg substrate when transcribing the Ecl136 II (Fermentas)-linearized plasmid with T7 RNA polymerase. Deletions in pA2-I were made by cloning overlapping oligonucleotides into the parental vector.
Drosophila species were obtained from the Tucson Stock Center, and evolutionary relationships can be viewed at http://flybase.bio.indiana.edu/allied-data /lk/phylogeny/Drosophilidae-Tree/. The ELAV binding site in ewg was amplified by inverse PCR. Briefly, DNA from ϳ10 flies was extracted as described by Koushika et al. (28) , and 1/10 was digested with either AseI or HypCH4 IV. After heat inactivation of restriction enzymes, the DNA was ligated in 400 l overnight at 4°C. PCR was done on 1/10 of the ligated DNA with primers ewgInv F1 (GTCGCCTGGAATGCACCAGATGATGATC) and ewgInv R1 (CTCCAGC TGRTCGCCATTCTCCAC) for 35 cycles (94°C for 30 s, 58°C for 60 s, and 72°C for 90 s, with an initial denaturation step at 94°C for 30 s and a final extension at 72°C for 5 min).
EMSA, gel filtration, and ELAV protein cross-linking. Production of recombinant proteins and electrophoretic mobility shift assays (EMSAs) were as described by Soller and White (55) . To test for protein activity, binding assays were as in EMSAs except that poly(U) RNA (Amersham) was used as the substrate, 0.05% NP-40 was added to buffers, and DEAE-Sepharose beads (Amersham) were blocked by 10% serum.
For gel filtration on Superose 6 (HR 10/30; Amersham), complexes were formed in the same way as for EMSA and run in 150 mM NaCl, 0.5ϫ Trisborate-EDTA at 4°C.
ELAV protein cross-linking was done in 75 mM HEPES (pH 7.3),120 mM NaCl, 2.5 mM EDTA in a final volume of 20 l by adding 1 l 1,8-bis-maleimidotriethyleneglycol (BM[PEO] 3 ) (Pierce) in water (at 1:1, 1:3, and 1:9 ratios of sulfhydryl groups to cross-linker). After 30 min at room temperature, the reaction was quenched for 15 min with 2 l 1 M glycine, 7.5 mM Na 2 HPO 4 , 250 mM dithiothreitol; the reaction mixture was mixed with sample buffer, and an aliquot was run on a sodium dodecyl sulfate (SDS) gel.
Boundary experiment. For 5Ј end labeling, substrate RNA was in vitro transcribed using a guanosine (Sigma)-to-GTP ratio of 8:1 according to standard procedures. Transcripts were 5Ј labeled with T4 polynucleotide kinase (NEB) and [␥- 32 VOL. 25, 2005 ELAV BINDS ewg RNA AS A MULTIMER 7581 50 mM NaHCO 3 -Na 2 CO 3 , pH 9.4, at 96°C for 5 to 10 min); complexes were formed as for EMSA analysis with an ELAV concentration of 2 M and run on an agarose-polyacrylamide composite gel (40) . ELAV complexes were cut out, agarose was digested with agarase, and the RNA was phenol-chloroform extracted and ethanol precipitated. RNA extraction, RT-PCR, and RPA. RNA extraction and reverse transcription-PCR (RT-PCR) were done as described by Soller and White (55) , and RNase protection assays (RPAs) were according to standard procedures. Nuclear extract preparation and UV-cross-linking assays were as described by Soller and White (55) .
RESULTS
ELAV forms a dodecameric complex on ewg pre-mRNA. We previously noted that several ELAVs form a complex upon binding to substrate RNA in EMSAs and that the complex formation concentration was dependent on the sequence of the substrate RNA (55) . Here we analyzed the stoichiometry of this ELAV complex that binds to ewg substrate RNA pA2-I (from pA2 to exon I [ Fig. 1E] ) and determined its RNA binding properties. For this analysis we used full-length ELAV and an N-terminally truncated ELAV mutant, RBD60, a hypomorph able to rescue lethal alleles of elav (Fig. 1A) (63) . Recombinant ELAV and RBD60 were bacterially produced as glutathione S-transferase fusion proteins and proteolytically cleaved off the glutathione S-transferase moiety (Fig. 1B) . Both ELAV and RBD were about 90% active in a poly(U) binding assay (Fig. 1C) . In EMSAs, the truncated RBD60 protein formed a faster-migrating complex than the ELAV complex, but otherwise dissociation constants (17 nM and 25 nM for ELAV and RBD60, respectively) were comparable and an initial complex formed at around 350 nM of ELAV or RBD60 (Fig. 1F [compare lanes 6 and 7 and lanes 12 and 13] and G,). Additionally, several intermediate shift products were detectable with both proteins, indicating that smaller ELAVor RBD60-RNA complexes run at intermediate positions (Fig.  1F , lanes 4, 5, 10, and 11).
Next, to obtain an estimate of the size of the ELAV complex bound to ewg RNA, we performed size exclusion chromatography experiments using 32 P-labeled RNA pA2-I complexed with recombinant, N-terminally hemagglutinin (HA)-tagged ELAV (54 kDa) or RBD60 (40 kDa) at saturating concentrations ( Fig. 2A and B) . The RNA-ELAV complex runs at a size of about 714 kDa as estimated from prerun standards under the same conditions. Most free ELAV protein runs at 229 kDa, with minor peaks at 95 kDa and 52 kDa. ELAV without RNA resulted in the same major peak at the size of 237 kDa, with minor peaks at 104 kDa and 57 kDa (Fig. 2C) . The RBD60-RNA complex runs at 498 kDa, and free RBD60 protein runs in three major peaks at sizes of 167 kDa, 67 kDa, and 33 kDa (Fig. 2B) . RBD60 without RNA resulted in two major peaks at sizes of 176 kDa and 73 kDa and a minor peak at 40 kDa (Fig.  2C) . Free RNA runs above its expected size of 72 kDa, at 198 kDa, due to the elongated nature of this 213-nt RNA (Fig. 2C) . Although retention on gel filtration columns is also influenced by the shape of a protein (complex), the presence of a major peak of free ELAV at around 216 kDa together with minor peaks at around 108 kDa and 54 kDa, and accordingly reduced sizes for RBD60, suggests that free ELAV forms a tetramer in solution. The free RBD60 tetramer is less stable than the full-length ELAV tetramer under these conditions, which indicates an involvement of the A/Q-rich N terminus in tetramer stability.
To verify the tetramer configuration of ELAV in solution, we physically cross-linked recombinant ELAV and RBD60. The two cysteine residues in ELAV ( Fig. 2D ) were used to cross-link ELAV or RBD60 in a maleimide reaction with BM-[PEO] 3 starting at equimolar amounts (1ϫ, 3ϫ, and 9ϫ), and cross-linked products were then detected on Western blots. With both ELAV and RBD60 three major band doublets corresponding to dimer, trimer, and tetramer sizes were detected at a concentration of 3 M (Fig. 2D , lanes 2 to 4 and 9 to 11). At a lower concentration of 0.75 M (and a fourfold reduced cross-linker concentration), the same bands were detected with ELAV, while RBD60 cross-linked predominantly as dimer, consistent with its reduced tetramer stability seen in gel filtration experiments ( 3 were obtained with other cross-linkers that preferentially target primary amines in lysine residues (e.g., glutaraldehyde). In these cases, however, the dimer product was more prominent, and increasing cross-linker concentrations resulted in degradation of ELAV or RBD60 due to attacks on peptide bonds (data not shown).
To gain further information about the stoichiometry of the ELAV complex and how ELAV assembles on its ewg target RNA, EMSAs were performed well above the dissociation constant. Under these conditions, formation of the ELAV complex is stoichiometric and the final ELAV-RNA complex is observed around a 1:12 ratio of RNA to ELAV or RBD60 ( Fig. 3A and B, lanes 9). As cooperative interactions among ELAV proteins compensate for a substoichiometric composition ( Fig. 3A and B), a defined complex forms at around a 1:9 ratio but is further retarded up to a 1:12 ratio ( Fig. 3A and B and data not shown). With both ELAV and RBD60, a total of six bands in addition to the input RNA were detected ( Fig. 3A and B, lanes 2 to 8), suggesting stepwise addition of dimers with each additional band up to a final complex of around 12 ELAVs. Plotting the amount of bound RNA against the equivalents of the protein-to-RNA ratio further indicates that assembly of the ELAV complex on ewg RNA occurs mostly as dimer units (Fig. 3C ). The RBD60 protein associates more readily with ewg pA2-I RNA than ELAV (Fig. 3C ), likely as a consequence of the reduced tetramer stability of RBD60 compared to ELAV. Although a semistable intermediate of ELAV at the tetramer size is observed (Fig. 3A, lane 7) , recruitment of ELAV into the ELAV RNA complex clearly involves rearrangement of the ELAV tetramer. Intermediate RBD60-RNA complexes appear not as sharp as the final RBD60 RNA complex in EMSAs, likely reflecting a decreased stability of these complexes (Fig. 3B) .
To exclude cooperative interactions among ELAVs for compensating for a substoichiometric composition of the final ELAV complex ( Fig. 3A and B) , ELAV was titrated against RBD60 at complex-forming concentrations (Fig. 3D ) to determine the number of ELAV molecules present in the ELAV complex formed on ewg RNA pA2-I. EMSA analysis showed that at 100% RBD60, only the fast-migrating complex was formed, but with increasing ELAV concentration, a ladder of complexes was observed, with all the RBD60 complex almost disappearing at 40%ELAV (Fig. 3D) . A closer inspection reveals 13 discrete complexes, suggesting that the final ELAV complex on ewg RNA pA2-I contains 12 ELAV molecules (Fig. 3D) . Finally, to show that only one RNA molecule is present in the final ELAV complex, we used a longer RNA containing two copies of the ewg ELAV complex-forming site pA2-I, mixed it with the regular one-copy pA2-I substrate RNA, and complexed this mixture with ELAV (Fig. 3E) . In EMSAs, two ELAV complexes separated, as expected for complexes that contain only one RNA (Fig. 3E, lane 6) .
The ELAV complex binding site on ewg RNA covers over 135 nucleotides. Parts of the RNA from pA2-I can be aligned (elements m1, m2, and m3) (55) , and mutations in each of these elements reduced ELAV binding in nuclear extracts in UV-cross-linking assays (55) . Therefore, these elements could potentially represent three individual binding sites, one for each ELAV tetramer. To address this issue, we made a series of end deletions in substrate RNA pA2-I and tested if they form FIG. 2. ELAV tetramerizes and forms a 700-kDa complex with ewg RNA pA2-I. (A and B) Superose 6 gel filtration of ELAV or RBD60 complexes. ELAV (A) or RBD60 (B) RNA-pA2-I complexes were formed with 10 fmol 32 P-labeled RNA pA-I and 320 pmol ELAV or RBD60 in 100 l and loaded onto the gel filtration column. The top panels show an exposure of the RNA elution profile and the middle panels a Western blot of the elution profile for ELAV (A) or RBD60 (B). The bottom panels show a quantification of RNA (dashed line) and ELAV (A) or RBD60 (B) elution profiles (solid line) in conjunction with prerun standards. Peaks of free ELAV or RBD60 are numbered according to their multimerization state (1, monomer; 2, dimer; and 4, tetramer). The protein peak is slightly retarded compared to the RNA peak, which might be due to the length of the run and substoichiometric stability of the complex (see Fig. 3A (6, 18 , and 36 M and 1.5, 4.5 and 13.5 M, respectively). Proteins were separated on a 7% SDS gel and detected by Western blotting with an anti-ELAV antibody. Lanes 1 and 8 show input protein without cross-linker (same preparation as in Fig. 1B) , and the multimerization state is labeled at the right of ELAV and RBD60 protein lanes, respectively. Since about 5 to 10% of a shorter proteolysis fragment is present, the lower of the two dimer bands might include this fragment, which is, however, not observed with tri-and tetramer adducts. The positions of the two cysteines in ELAV are depicted in a schematic of ELAV above the gel. (Fig. 4) . The length of substrate RNAs ranges from 67 to 213 nt, including 43 nt of vector sequence (see Materials and Methods for details).
Deleting different parts of substrate RNA pA2-I results in either ELAV complexes of comparable size, indicating recruitment of a fixed number of ELAV molecules (Fig. 4C , lanes 5, 6, 11, 12, 17, and 18, and D, lanes 5, 6, 11, 12, and 17 to 19), or absence of binding and complex formation (RNAs ⌬134 and ⌬5 to ⌬7) ( Fig. 4B and D, lane 20) . In contrast, input RNAs separate according to their size (Fig. 4C, lanes 1, 7, and 13 , and D, lanes 1, 7, 13, and 20). Further, deletion of AU 4-6 motifs reduces binding affinity, which is indicated by an increasing K d as determined from EMSA ( Fig. 4B and E) . In addition, an increasing slope of the binding curve with shorter RNAs suggests that cooperativity among ELAV compensates for suboptimal binding sites in these shorter RNAs (Fig. 4E) . AU [4] [5] [6] motifs in the m3 element and the polypyrimidine tract, however, are more important for full-affinity binding of ELAV than AU 4-6 motifs in the m1 and m2 element. Since ELAV forms a similar-size complex on substrate RNA Py (67 nt), sequence composition matters and those RNAs which do not bind ELAV are not simply too short (RNAs ⌬134 and ⌬5 to ⌬7, 70 to 74 nt) (Fig. 4B and D and data not shown) . In summary, these experiments suggest that RNA from pA2 to exon I consists of a single ELAV complex binding site leading to formation of a dodecameric ELAV complex.
ELAV complex formation requires no unique binding element. Next, we wanted to determine the part of the RNA pA2-I that is covered by the ELAV complex. To map the boundaries, pA2-I RNA was either 5Ј or 3Ј end labeled, partially hydrolyzed to a single-nucleotide ladder, and complexed with ELAV. The ELAV complex was then purified from an EMSA gel, and the RNA was extracted and analyzed on a denaturing gel. ELAV forms the same sized complex with partially hydrolyzed RNA as with full-length pA2-I RNA (Fig. 4D, lanes 5, 6, 11 , 12, and 17 to 19), and no clearly defined intermediate-sized complexes appear that could be purified (data not shown). Analysis of the RNA complexed with ELAV revealed that with both 3Ј-and 5Ј-labeled substrate, ELAV complex formation starts with relatively short RNAs (Fig. 5A and B) . 5Ј-labeled RNA is present after a length of about 58 nt (Fig. 5A,  lane 4) , and 3Ј labeled RNA is present after 43 nt (Fig. 5B, lane  4) . Labeling intensity increases continuously with the length of the RNA for both end-labeled substrates. Particularly, for 5Ј-labeled substrate affinities to bind RNAs dramatically increase after the m1 element (Fig. 5A, lane 4) , and for 3Ј-labeled substrates they increase after the pyrimidine tract (Fig. 5B,  lane 4) . Comparable results were obtained with end-labeled RNA ⌬12 (Fig. 4B) ; namely, 5Ј-labeled RNA is present after a length of about 47 nt (after the m3l element) and 3Ј labeled RNA also after 43 nt, as was observed with pA2-I RNA (data not shown). In conclusion, overlapping of 5Ј and 3Ј selected RNAs indicates the absence of a unique sequence element for binding (Fig. 5C ). Unlike for other RNA binding proteins, which bind to a specific motif in a longer sequence context (e.g., Nova or FMRP) (15, 16) , length in combination with uridine repeats seems to be important for ELAV complex formation in this assay.
Phylogenetic comparison of the ewg ELAV complex binding site. To independently identify regulatory elements, we sequenced a series of closely related species from the Drosophila melanogaster group for phylogenetic comparisons. This allows An alignment of the sequences between pA2 and exon I of 13 closely related species from all six subgroups belonging to one of the main branches in the melanogaster species group is shown in Fig. 6A (see Materials and Methods for links to phylogenetic trees in Flybase). Splicing and polyadenylation signals are well conserved in all species (Fig. 6A) . In addition, six AU 4-6 motifs are conserved, and each one might represent the binding site for one ELAV dimer according to the assembly in Fig. 3 . Consistent with our in vitro binding data (Fig. 4) , the m3r element and polypyrimidine tract show the highest conservation (Fig. 6A) . Although the adenine is strictly present in the D. melanogaster AU 4-6 motifs, replacement with guanosine is found in other species, and uracil is sometimes replaced by cytosine. Further conserved sequences are found around several AU 4-6 motifs, particularly in the m1r, m2r, m3l, and m3r elements. Surprisingly, m1l, m2l, and m3m elements start either to diverge or are deleted, pointing out that binding platforms for individual parts of the ELAV complex show flexibility in spatial positioning.
Multiple AU 4-6 motifs contribute to ELAV-dependent regulation of ewg in vivo. Since introducing mutations in each individual AU 4-6 element (m1, m2, and m3) reduced ELAV binding in nuclear extracts when UV-cross-linking was used (55), we wanted to test if AU 4-6 motifs of individual elements m1, m2, and m3 contribute to ELAV-mediated splicing regulation of ewg intron 6 in neurons and if these contributions correlate with our data on ELAV complex formation in vitro. Therefore, we introduced AU 4-6 mutations in individual elements and combinations thereof into the tcgER reporter gene and established transgenic fly lines (Fig. 7A) (55) . RPAs were used to examine ewg pre-mRNA processing in dissected thirdinstar larval brains with probes around the HA and vesicular stomatitis virus (VSV) tags to protect spliced and unspliced RNA (Fig. 7A) .
In the mutant m1-3, splicing of intron 6 was about 20-fold reduced compared to that in the wild-type reporter transgene in larval brains (Fig. 7B, lanes 1 and 2) . Similar results were obtained with RT-PCR analysis of RNA from developing photoreceptor neurons (Fig. 7C, lanes 1 and 2) and with larval brains (data not shown).
In contrast to the transgene carrying mutation m1-3, mutations in AU 4-6 motifs of one element (m1 or m3) revealed a minimal effect on intron 6 splicing ( Fig. 7B and C, lanes 3 and  6) . When AU 4-6 motifs of two elements (m1ϩ2 or m2ϩ3) are mutated, a more pronounced effect is seen (Fig. 7B and C,  lanes 4 and 5) . Mutations in elements m2ϩ3 are about twice as effective as mutations in elements m1ϩ2 in reducing intron 6 splicing ( Fig. 7B and C, compare lanes 4 and 5) , but the reduction in intron 6 splicing is far below the effect observed with mutations in all AU 4-6 motifs (m1-3) (Fig. 7B and C, lane  2) . Levels of intron 6 splicing are comparable in larval brains (Fig. 7B) and in developing photoreceptor neurons (Fig. 7C) . We thus conclude that in vivo multiple AU 4-6 motifs contribute to ELAV-mediated splicing of intron 6, which supports our in vitro data on ELAV acting as a macromolecular complex spread over 135 nt. Spacing between conserved AU 4-6 elements is not critical for ELAV-dependent regulation of ewg in vivo. Phylogenetic analysis suggests that spacer regions between individual AU 4-6 motifs can vary in length, as some species have small deletions in nonconserved areas of the ewg ELAV complex binding site but no obvious compensations for this loss (Fig. 6A) . To test if this is indeed the case, we introduced 30-nt spacers (between m1 and m2, between m2 and m3, and between m3m and m3r elements) in regions which harbor deletions and/or are less conserved ( Fig. 6A and 7A ). As sequence for these spacers, the reversed complementary sequence following the insertion site was chosen, since it is A rich and not U rich but has a composition frequently found in introns.
Splicing of intron 6 was analyzed in transgenic flies carrying spacer insertions in the tcgER rescue reporter gene. Only marginal differences in intron 6 splicing were observed in transgenes with spacer insertions between m1 and m2 and between m2 and m3 elements (Fig. 7D, compare lane 1 with  lanes 3 and 4) . A spacer insertion between elements m3m and m3r had a slight stimulatory effect on splicing of intron 6 in neurons (Fig. 7D, lane 5) . Since additional RNA binding proteins could bind to the spacer elements and act in a compensatory manner together with ELAV, we did UV-cross-linking assays with spacer-containing substrate RNAs in neuronal nuclear extracts. No additional RNA binding proteins were detected (data not shown). These results suggest that spacer regions between individual elements involved in ELAV binding and complex formation can vary in length.
DISCUSSION
The experiments presented in this paper show that ELAV forms a dodecameric complex upon binding to ewg RNA pA2-I and that multiple and phylogenetically conserved AU 4-6 motifs spread over 135 nt are important for high-affinity binding in vitro and regulation of ewg intron 6 splicing in vivo. Thus, the ability of a binding site to support multimeric ELAV complex formation may provide the answer to the puzzle of how ELAV achieves target specificity in vivo in light of its general binding preferences for short AU-rich sequences that are abundant in noncoding regions of transcripts. Below we discuss the composition and the assembly of ELAV into a multimeric complex with regard to the organization of the first characterized ELAV complex binding site in the ewg gene. We further point out implications of these findings in target gene regulation and posttranscriptional control of gene networks. Evidence for a dodecameric ELAV complex on ewg RNA pA2-I. Based on several lines of evidence, we propose a model for a multimeric ELAV complex consisting of 12 ELAV molecules that associate with ewg RNA between pA2 and exon I in intron 6 in vitro. First, ELAV assembles with RNA into a defined and saturable RNA-protein complex when assayed by EMSA. This association occurs in an RNA substrate-specific manner, as some RNAs do not form an ELAV-RNA complex even at a concentration of 3.2 M (⌬134, ⌬5 to ⌬7), which thus clearly distinguishes the ELAV-RNA complex from an unspecific aggregation. Second, two substrate RNAs of different size form two separable complexes, demonstrating that only one RNA is present in the final ELAV complex. Third, in size exclusion chromatography experiments under physiological salt conditions, ELAV bound to ewg RNA pA2-I results in a defined complex of about 700 kDa, and the smaller RBD60 protein yields an RNA-protein complex of appropriately reduced size of about 500 kDa, suggesting assembly of a complex in the range of 12 protein molecules. Fourth, in stoichiometry EMSAs the final ELAV complex forms at around a ratio of FIG. 7 . Inhibition of 3Ј end formation at pA2 depends on ELAV binding at multiple and spaced AU [4] [5] [6] motifs in vivo. (A) Schematic of the last ewg intron 6 and 3Ј UTR with splicing and polyadenylation choices as present with HA and VSV tags in the tcgER rescue reporter construct (top) (55). The two major isoforms are those with intron 6 spliced from H to J in the presence of ELAV (solid line) or with polyadenylation in intron 6 at pA2 in the absence of ELAV. ewg probes used for RPA are shown in the middle. A magnification of the ELAV binding region is shown at the bottom, depicting polyadenylation site pA2 and part of exon I as well as AU 4-6 motif and spacer mutations introduced into tcgER reporter transgenes. (B) RPA of RNA prepared from 20 third-instar larval brains from wild-type and AU 4-6 motif mutants of ewg rescue reporter construct transgenes in a wild-type elav background. After purification, RNA was run on a 6% denaturing gel. Protected fragments are indicated at the right, and protected fragments from endogenous ewg transcripts are indicated by asterisks. The fragment marked with x derives from exon J of the transgene (judged by its accumulation following the usage of intronic polyadenylation sites). The loading control protects a fragment from Appl. Quantification of protected fragments from intron 6 (unspliced) to spliced transcripts is shown at the bottom of the panel. Additional lines with independent insertions from each construct gave comparable results. (C) Splicing of ewg intron 6 analyzed by quantitative RT-PCR (primers 6F and VSV-R) with RNA extracted from third-instar eye imaginal disks from wild-type and AU 4-6 motif mutants of ewg reporter construct transgenes in a wild-type elav background. For total transcripts a 5Ј fragment of the reporter transcript was amplified with primers eeF and eeR (55) . Uniformly 32 P-dCTP labeled PCR products were separated on 8% polyacrylamide gels. (D) Splicing of ewg intron 6 analyzed by quantitative RT-PCR with RNA extracted from third-instar eye imaginal disks from wild-type and spacer mutants of ewg reporter construct transgenes in a wild-type elav background. For total transcripts a 5Ј fragment of the reporter transcript was amplified with primers eeF and eeR. Uniformly 32 P-dCTP labeled PCR products were separated on 8% polyacrylamide gels. Quantification from three independent insertions is shown as means at the bottom. Although the tools to demonstrate an in vivo assembly of a dodecameric ELAV complex with target RNA in fly neurons are currently not available, circumstantial evidence supports the presence of large ELAV-RNA complexes in vivo. In the nucleus, ELAV has been found to sublocalize to sites of higher concentration in discrete dots and webs (62) , indicating that complex formation with ewg pA2-I RNA at around 350 nM in vitro could meet in vivo conditions. Further, Hu proteins have also been shown to be present in large particles in cells and neurites (5, 7, 25, 54) . Although ELAV shares the tetramer configuration characteristics with general heterogeneous nuclear ribonucleoprotein particle (hnRNP) proteins (for reviews, see references 18, 30, 39, and 61), binding to RNA induces a rearrangement into dimers. In addition, the ELAV complex forms on 43 to 135 nucleotides of RNA pA2-I, while a tetramer unit of general hnRNPs isolated from 40S particles binds to 200 to 240 nt (23, 37) , and the RNA present in the 40S particle is about 500 to 800 nt in length (12, 18, 37) . The length differences of the RNAs present in the ELAV complex and general hnRNP complexes likely reflect a different packaging mode. Models for hnRNP C binding to RNA have favored a loose wrapping around the tetramer (51) . For an ELAV-RNA complex, however, a different model might apply, as the two RRMs of Sex-lethal (Sxl) and the first two RRMs of HuD, both closely related to ELAV, were shown to cover 11 nt in cocrystallization experiments (22, 60) . A linear assembly of 12 ELAVs with RNA is therefore unlikely, particularly with RNAs as short as 43 nt, unless not all RRMs are in contact with RNA in such a complex. Moreover, phylogenetically conserved AU 4-6 motifs contain only 5 to 7 nucleotides. A possible alternate model for the assembly of the ELAV complex might therefore include that ELAV surrounds the RNA upon binding, similar to the core of Sm proteins bound to snRNA (24) .
Although our data point towards a dodecameric ELAV complex bound to RNA pA2-I, based on the titration experiments in Fig. 3 , and to an ELAV tetramer in solution, based on gel filtration and protein cross-linking data, alternative interpretations of these data are also possible. For example, titration of ELAV with RBD60 in EMSAs could result in an overestimation of the stoichiometry, as RNA-protein complexes of identical composition but with different conformations could appear as distinguishable bands in EMSAs. Further, ELAV complex size might also be overestimated in gel filtration experiments due to an elongated shape or interaction with the column matrix, as illustrated by the following example. Initial experiments with polypyrimidine tract binding protein (PTB) indicated dimerization in solution, as deduced from gel filtration experiments that were supported by protein-protein interaction assays (41, 44) . More recent experiments using physical methods, however, revealed that PTB is predominantly a monomer in solution and that the larger size of PTB in gel filtration is attributed to its elongated shape and the N-terminal 55-amino-acid auxiliary domain of PTB (2, 53) . According to these recent data, earlier results from cross-linking experiments might have shown only a minor portion of PTB that is associated into a dimer, and interaction in yeast two-hybrid assays might have been due to unspecific binding to yeast RNA as PTB dimerizes on c-src RNA (2) . Similar to the PTB scenario, we might overestimate the ELAV complex, and further physical experiments are needed to prove our model.
Sequence features of the ewg ELAV complex binding site. The assembly of a dodecameric ELAV complex on RNA pA2-I suggests that an array of repetitive cis elements might mediate complex formation. Results from various approaches show that a series of AU [4] [5] [6] motifs present between pA2 and exon I in the last ewg intron are important for ELAV complex binding (this study and reference 55). First, using RNA substrates with mutations in AU 4-6 motif element m1, m2, or m3 demonstrated that all elements spread over 135 nt contribute to ELAV binding in vitro in UV-cross-linking assays and EMSAs (55) . Second, UV-cross-linking assays with segmentally labeled substrate RNAs using RNA pA2-ivs further demonstrate that the ELAV complex binding site extends over about 135 nt (55) . Third, phylogenetic analysis of the ELAV binding site reveals evolutionary conservation of six AU 4-6 motifs, suggesting that an ELAV dimer might bind per AU 4-6 motif. Fourth, functional importance in vivo of AU 4-6 motifs is further shown in ELAV-mediated splicing of the last ewg intron, using Drosophila transgenes. Although an array of AU 4-6 motifs is important for ELAV complex formation, not all AU 4-6 motifs contribute equally. In particular, AU 4-6 motifs in the m3 element and the polypyrimidine tract have a much higher impact on high-affinity binding than the m1 and m2 elements, both in vitro and in vivo. A similar situation has been observed in the hnRNP A1 binding site in intron 3 of human immunodeficiency virus tat transcripts, and the following model has been proposed. A few hnRNP A1 molecules bind first to the high-affinity portion of the binding site and then recruit further hnRNP A1 molecules to nucleate to a higher-order complex (13, 65) . A similar model might also apply to ELAV complex formation. Here, high-affinity binding of few ELAV molecules to the 3Ј part of the complex binding site could lead to recruitment of more ELAVs that will enhance complex formation in the presence of additional AU 4-6 motifs. Alternatively, clustering of binding motifs might enhance cooperative interactions among ELAVs that then trigger formation of a stable complex upon reaching local concentrations close to the stoichiometry of the final ELAV complex at a specific target site, thereby contributing to gene-specific recognition of target RNAs.
The ewg ELAV complex binding site from the melanogaster species subgroup harbors three tandem AU 4-6 motifs (in m1, m2, and m3 elements) that can be aligned (55) . Collectively, the results presented here argue against tandem AU 4-6 motifs in element m1, m2, or m3 either as individual tetramer binding sites or as overlapping binding sites for two tetramers. First, ELAV assembles as dimers in stoichiometry EMSAs. Second, deleting tandem AU 4-6 motifs does not result in ELAV complexes of intermediate size, as no one-or two-tetramer complexes are detected as the main product in EMSAs. Rather, ELAV complex formation and its affinity for a specific substrate RNA depend on length and poly(U) content of the substrate RNA. Third, tandem AU 4-6 motifs in the m1 and m2 elements are not sufficient for complex formation in EMSAs. Fourth, only six AU 4-6 motifs (m1r, m2r, m3l, m3r, and two in the polypyrimidine tract) are evolutionarily conserved. The additional AU [4] [5] [6] motifs present in the melanogaster species subgroup might therefore represent redundancy. This is also indicated by the minimal difference in affinity between RNA pA2-I, ⌬1, and ⌬12 in EMSAs, as the remaining AU 4-6 motifs still suffice for almost optimal positioning of the ELAV complex in this assay.
Implications for regulation of target genes. Besides increasing binding specificity, multimerization of RNA binding proteins might also provide a mechanism to locate distant RNAprocessing signals by looping out intronic sequence to bring splice sites into proximity. The organization of the ELAV complex binding site illustrates flexibility in positioning of AU 4-6 motifs relative to each other, as they are not strictly conserved between different Drosophila species and introducing spacer sequences only marginally affects processing of the last ewg intron 6. Forming a complex with distant recognition sequences also offers an appealing explanation for ELAVmediated regulation of pre-mRNA processing in the more complex situation of nrg, where a distal terminal exon is chosen in the presence of ELAV (27) . UV-cross-linking studies of the whole nrg-regulated intron revealed four areas of binding in the vicinity of splice sites and poly(A) signals (34) . An ELAV complex bound to these extensively spaced binding sites would exclude nonneuronal RNA-processing signals from recognition. A similar model has been proposed for autoregulation of hnRNP A1 alternative splicing. Here, hnRNP A1 binds sequences flanking both sides of the regulated exon, leading to skipping of this exon (8) .
Functional importance of multimerization has also been indicated for hnRNP A1-regulated alternative splicing of intron 3 from human immunodeficiency virus tat transcripts. Here, multimerization of hnRNP A1 in the context of RNA secondary structure on intronic and exonic splicing silencer sequences competes with other factors for exon recognition (13, 56, 65) . In the case of PTB-regulated splicing of a neural exon in c-src (11), a neuronal form of PTB, nPTB, is postulated to interfere with multimerization of PTB and release the blocked exon for inclusion in neurons (38) . nPTB has also been found to interact with Nova-1 and to inhibit Nova-1-stimulated GlyR␣2 E3A alternative splicing (46) . In Drosophila, overexpression of the ELAV family member FNE can regulate expression of ELAV, similar to autoregulation by ELAV at endogenous levels (50) . As ELAV family members interact in yeast two-hybrid assays, they likely can also form heteromultimeric complexes in vivo (21, 25 ; L. Toba and K. White, unpublished data), and multimeric binding of HuB at the c-myc 3Ј UTR has been indicated (20, 32) . In addition, many other RNA binding proteins have also been shown to engage in homo-and heterophilic interactions (see, e.g., references 21, 47, and 49).
In conclusion, multimerization of RNA binding proteins into macromolecular complexes likely is an important feature of this abundant class of proteins to localize pre-mRNA processing signals in a complex cellular environment in constitutive splicing and affect use of alternative splice and polyadenylation sites. In addition, multimerization of RNA binding proteins might also provide the combinatorial setup to posttranscriptionally coordinate the expression of functionally related genes in higher eukaryotes, as postulated by Keene and Tennenbaum (26) .
